CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. DISTRIBUTION AGREEMENT (CANADA)Distribution Agreement • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • Minnesota
Contract Type FiledAugust 13th, 2003 Company Industry JurisdictionTHIS AGREEMENT is made as of June 1, 2003 (“Effective Date”), by and between Micro Therapeutics, Inc., a Delaware corporation with its principal place of business at 2 Goodyear, Irvine California (“MTI”) and ev3 Canada, Inc., a Canadian corporation with its principal place of business at 4600 Nathan Lane North, Plymouth MN 55442-2890 U.S.A. (“ev3”).
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. DISTRIBUTION AGREEMENT (JAPAN)Distribution Agreement • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • Minnesota
Contract Type FiledAugust 13th, 2003 Company Industry JurisdictionTHIS AGREEMENT is made as of June 1, 2003 (“Effective Date”), by and been Micro Therapeutics, inc., a Delaware corporation with its principal place of business at 2 Goodyear, Irvine California (“MTI”) and ev3 K.K., a Japanese corporation with its principal place of business at 2-28-I, Nihonbashi-Hamacho, Chuo-ku, Tokyo (“ev3”).
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. DISTRIBUTION AGREEMENTDistribution Agreement • August 13th, 2003 • Micro Therapeutics Inc • Surgical & medical instruments & apparatus • Minnesota
Contract Type FiledAugust 13th, 2003 Company Industry JurisdictionTHIS AGREEMENT is made as of April 30, 2003 (“Effective Date”), by and between Micro Therapeutics, Inc., a Delaware corporation with its principal place of business at 2 Goodyear, Irvine California (“MTI”) and ev3 Inc., a Delaware corporation with its principal place of business at 4600 Nathan Lane North, Plymouth MN 55442-2890 U.S.A. (“ev3”).